Team Rapid Novor will be touring Europe in the next several weeks. The first conference is the European Antibody Congress, 29 – 31 October 2018, Congress Centre, Basel, Switzerland. Booth #18.
At the conference, our co-founder and CEO, Mingjie, will talk about the goal, the challenges and our REmAb™ approach towards antibody protein sequencing. He will share in greater details the experiences and best practices we developed when advancing the sequencing technologies in both throughput and complexity dimensions. We invite you to attend his talk and connect with us at our booth.
The team will be travelling in Switzerland, The Netherlands, Germany, France and Portugal to meet customers. We’d love to meet you in person. Please drop us an email at sales@rapidnovor.com and we will contact you to book a meeting.
Related Posts
Talk to Our Scientists.
We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 9000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics